Literature DB >> 4551010

A trial of amylopectin sulfate (SN-263) and propantheline bromide in the long term treatment of chronic duodenal ulcer.

J B Cocking.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4551010

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  11 in total

Review 1.  Drugs in the treatment of gastric and duodenal ulcer.

Authors:  M J Langman
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

2.  Double-blind controlled trial of amylopectin sulphate (Depepsen) in the symptomatic treatment of duodenal ulcer.

Authors:  J H Baron; R J Gribble; D J Holdstock; J J Misiewicz
Journal:  Gut       Date:  1977-09       Impact factor: 23.059

3.  Antipeptic activity of a sulfate glycopeptide different behavior with purified human pepsin or human gastric juice.

Authors:  G Prino; A Lietti; G Allegra
Journal:  Am J Dig Dis       Date:  1972-10

Review 4.  Current therapy in peptic ulcer.

Authors:  I N Marks
Journal:  Drugs       Date:  1980-10       Impact factor: 9.546

5.  Treatment of peptic ulcer disease- a symposium.

Authors:  J H Meyer; A Schwabe; J I Isenberg; R A Sturdevant; M I Grossman; E Passaro
Journal:  West J Med       Date:  1977-04

6.  Medical treatment of gastric and duodenal ulcer.

Authors:  J H Baron
Journal:  Klin Wochenschr       Date:  1976-10-01

7.  Carbenoxolone sodium capsules in the treatment of duodenal ulcer. An endoscopic controlled trial.

Authors: 
Journal:  Gut       Date:  1977-09       Impact factor: 23.059

8.  Endoscopic evaluation of the effect of sucralfate therapy and other clinical parameters on the recurrence rate of gastric ulcers.

Authors:  T Miyake; J Ariyoshi; T Suzaki; M Oishi; M Sakai; S Ueda
Journal:  Dig Dis Sci       Date:  1980-01       Impact factor: 3.199

Review 9.  Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

10.  Double-blind randomised clinical trial of a pepsin-inhibitory pentapeptide (pepstatin) in the treatment of duodenal ulcer.

Authors:  O Bonnevie; L B Svendsen; J Holst-Christensen; T S Johansen; J Søltoft; P M Christiansen
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.